UnknownPhase 2

Effect of Oral Supplementation With Curcumin in Patients With Proteinuric Diabetic Kidney Disease

Mexico100 participantsStarted 2016-05

Plain-language summary

The purpose of this study is to determine if the oral supplementation with curcumin reduces proteinuria, improves the redox and pro-inflammatory state in patients with chronic kidney disease associated to Diabetes mellitus.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of Diabetes Mellitus type 2 and proteinuric kidney disease with 1000 mg of more proteins in daily recollection * Glomerular filtration rate between 15-60 mL/min/ 1.73 m2 calculated by CKD-EPI * Patients taking Angiotensin II Receptor Blocker or ACE inhibitors Exclusion Criteria: * Renal replacement therapy * Autoimmune disease or malignancy * Pregnancy * Hepatic damage * Congestive heart failure classification III or IV (NYHA) * History of organ transplantation * History of chemotherapy or immunosuppression within 2 years prior to screening

What they're measuring

Urine protein excretion

Timeframe: 24 weeks

Trial details

NCT IDNCT03019848

SponsorInstituto Nacional de Cardiologia Ignacio Chavez

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-05

Contact for this trial

Magdalena Madero, MD

55-5573-2911 madero.magdalena@gmail.com

View on ClinicalTrials.gov More Proteinuria trials